The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-2-(6-(2-Amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]-pyrimidin-6-yl)hexanamido)pentanedioic Acid ID: ALA3086864
PubChem CID: 136240255
Max Phase: Preclinical
Molecular Formula: C17H23N5O6
Molecular Weight: 393.40
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Nc1nc2[nH]c(CCCCCC(=O)N[C@@H](CCC(=O)O)C(=O)O)cc2c(=O)[nH]1
Standard InChI: InChI=1S/C17H23N5O6/c18-17-21-14-10(15(26)22-17)8-9(19-14)4-2-1-3-5-12(23)20-11(16(27)28)6-7-13(24)25/h8,11H,1-7H2,(H,20,23)(H,24,25)(H,27,28)(H4,18,19,21,22,26)/t11-/m0/s1
Standard InChI Key: DSEZCYKANVEUMR-NSHDSACASA-N
Molfile:
RDKit 2D
28 29 0 0 0 0 0 0 0 0999 V2000
2.9248 -18.9357 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.9236 -19.7552 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6317 -20.1642 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.6299 -18.5268 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3385 -18.9321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3433 -19.7507 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1233 -19.9991 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.6007 -19.3340 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1156 -18.6746 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2156 -20.1633 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.6275 -17.7096 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.4179 -19.3292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8223 -18.6191 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6395 -18.6143 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0439 -17.9042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8611 -17.8994 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2655 -17.1893 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0827 -17.1844 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.8527 -16.4840 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.4871 -16.4743 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3043 -16.4695 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0743 -15.7691 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2572 -15.7739 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.4787 -15.0590 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.7170 -17.1748 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5342 -17.1700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9470 -17.8753 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.9386 -16.4599 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 6 1 0
5 4 1 0
4 1 1 0
5 6 2 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
2 10 1 0
4 11 2 0
8 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
17 19 2 0
20 18 1 6
20 21 1 0
20 22 1 0
22 23 2 0
22 24 1 0
21 25 1 0
25 26 1 0
26 27 1 0
26 28 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 393.40Molecular Weight (Monoisotopic): 393.1648AlogP: 0.37#Rotatable Bonds: 11Polar Surface Area: 191.26Molecular Species: ACIDHBA: 6HBD: 6#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 7#RO5 Violations (Lipinski): 2CX Acidic pKa: 3.64CX Basic pKa: 4.98CX LogP: -1.05CX LogD: -6.00Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.29Np Likeness Score: 0.30
References 1. Wang Y, Cherian C, Orr S, Mitchell-Ryan S, Hou Z, Raghavan S, Matherly LH, Gangjee A.. (2013) Tumor-targeting with novel non-benzoyl 6-substituted straight chain pyrrolo[2,3-d]pyrimidine antifolates via cellular uptake by folate receptor α and inhibition of de novo purine nucleotide biosynthesis., 56 (21): [PMID:24111942 ] [10.1021/jm401139z ]